XNAS
IMCC
Market cap1mUSD
Oct 08, Last price
1.72USD
1D
-9.47%
1Q
-63.01%
Name
IM Cannabis Corp
Chart & performance
P/E
—
P/S
0.03
EPS
—
Div yield, %
—
Shrs. gr., 5y
-48.38%
Rev. gr., 5y
28.06%
Revenues
55m
+1.30%
Net income
-11m
L+6.93%
CFO
5m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Key people
Chairman of the Board, President, Chief Executive Officer · since 2010
Chief Financial Officer · since 2018
Navjit Dhaliwal
Director · since 2018
Timothy D. Towers
Director · since 2017
Russell George Williams
Independent Director · since 2010
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑04 | 2018‑12 | 2018‑04 | 2017‑04 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||